Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility
Agreement is the latest step in execution of the Company's strategy to support onshoring of logistical and operational activities for international companies to the U.S.
SPRING BRANCH, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has entered a preliminary agreement with the maker of an oral drug delivery system to install its innovative manufacturing equipment in Callan JMB's cGMP facility in Texas, while the two companies negotiate operational agreements.
Callan JMB is entering the first phase of a collaboration combining Callan JMB's capabilities in cGMP warehousing, licensing, certification, and drug distribution with the new client's game-changing manufacturing equipment that creates oral fast-dissolving strips to provide an alternative to intravenous injections for numerous over-the-counter medicines.
"We are excited about this new partnership and the opportunities that installing the client's manufacturing technology at our facility will open up for safe and effective oral drug delivery," said Wayne Williams, CEO of Callan JMB. "This agreement is in line with our goals for expansion into ground-breaking healthcare and wellness technologies."
Callan JMB sees the agreement as a fitting progression from its existing capacity for storage and distribution of finished medical products into the sourcing and use of Active Pharmaceutical Ingredients ("APIs") in new manufacturing processes. This agreement is the latest step toward several related initiatives that are in the planning stages with global manufacturing leaders in the healthcare industry, such as Revival Health.
About Callan JMB
Callan JMB is an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.
Forward-Looking Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs, such as "will," "should," "would," "may," and "could," are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge on the SEC's website at: http://www.sec.gov. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, and disclaims any intention or obligation to update or revise any such forward-looking statements to reflect events or circumstances that subsequently occur, or of which the Company hereafter becomes aware.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
[email protected]
212.896.1254
